GI
DNTH icon

GAMMA Investing’s Dianthus Therapeutics DNTH Stock Holding History

GAMMA Investing’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$49.1K Buy
558
+254
+84% +$26.4K ﹤0.01% 2376
2026
Q2 		$29.6K Buy
304
+46
+18% +$4.02K ﹤0.01% 2618
2026
Q1 		$21.7K Buy
258
+24
+10% +$1.39K ﹤0.01% 2674
2025
Q4 		$9.64K Buy
234
+39
+20% +$1.51K ﹤0.01% 2997
2025
Q3 		$7.67K Buy
195
+69
+55% +$1.76K ﹤0.01% 3001
2025
Q2 		$2.35K Sell
126
-88
-41% -$1.65K ﹤0.01% 3361
2025
Q1 		$3.88K Buy
214
+90
+73% +$1.98K ﹤0.01% 3186
2024
Q4 		$2.7K Buy
124
+118
+1,967% +$3.03K ﹤0.01% 3128
2024
Q3 		$164 Buy
+6
New +$167 ﹤0.01% 3526

Other funds holding DNTH

GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's DNTH Position: Q3 2026 in Review

GAMMA Investing increased its Dianthus Therapeutics (DNTH) stake by 84% in Q3 2026, buying an estimated $26.4K and bringing the position to 558 shares worth $49.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

GAMMA Investing first reported a position in DNTH in Q3 2024 and has held it in 9 quarters since. 5 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • GAMMA Investing held 558 shares of Dianthus Therapeutics worth $49.1K as of Q3 2026.
  • GAMMA Investing bought 254 Dianthus Therapeutics shares in Q3 2026, an estimated $26.4K.
  • Dianthus Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2376 holding.
  • GAMMA Investing first reported a position in Dianthus Therapeutics in Q3 2024 and has held it in 9 quarters since.
  • 5 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.